| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ANA.23797 |
| P8608 | Fatcat ID | release_u5aygf3gw5g6jbbogmgd7lydwu |
| P932 | PMC publication ID | 3725727 |
| P698 | PubMed publication ID | 23596051 |
| P5875 | ResearchGate publication ID | 236225325 |
| P50 | author | Steven T. DeKosky | Q7615308 |
| William E. Klunk | Q30223705 | ||
| Howard J Aizenstein | Q42374777 | ||
| Lewis Kuller | Q88077314 | ||
| Bedda L Rosario | Q125350276 | ||
| P2093 | author name string | M Ilyas Kamboh | |
| Lisa A Weissfeld | |||
| Oscar L Lopez | |||
| Julie C Price | |||
| Judith A Saxton | |||
| Chester A Mathis | |||
| Brian J Lopresti | |||
| Beth E Snitz | |||
| Eric M McDade | |||
| P2860 | cites work | Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B | Q29012704 |
| Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade | Q29614407 | ||
| Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. | Q30433809 | ||
| Ginkgo biloba for prevention of dementia: a randomized controlled trial | Q30437036 | ||
| Disruption of functional connectivity in clinically normal older adults harboring amyloid burden | Q30492809 | ||
| The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. | Q31037161 | ||
| Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease. | Q31108280 | ||
| Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease | Q33560183 | ||
| Amyloid imaging in mild cognitive impairment subtypes. | Q33689424 | ||
| APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging | Q33695738 | ||
| Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. | Q33697980 | ||
| Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden | Q33803956 | ||
| Comparison of 18F-FDG and PiB PET in cognitive impairment | Q33917282 | ||
| Alzheimer disease identification using amyloid imaging and reserve variables: proof of concept | Q34004313 | ||
| The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core | Q34061794 | ||
| Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET. | Q34672421 | ||
| Role of the neuropathology of Alzheimer disease in dementia in the oldest-old | Q34764490 | ||
| Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18 F-FDG) PET in patients with Alzheimer disease, mild cognitive impairment, and healthy controls | Q35032948 | ||
| Neuropathologic features associated with Alzheimer disease diagnosis: age matters | Q35529951 | ||
| Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old | Q35606753 | ||
| Incidence and prevalence of dementia in the Cardiovascular Health Study | Q35631591 | ||
| Alzheimer's and dementia in the oldest-old: a century of challenges | Q36026972 | ||
| Frequent amyloid deposition without significant cognitive impairment among the elderly | Q37085957 | ||
| Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease | Q37149705 | ||
| Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease | Q37181302 | ||
| 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease | Q37363776 | ||
| Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease | Q37402317 | ||
| Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease | Q38394208 | ||
| Neuropathology of older persons without cognitive impairment from two community-based studies | Q38405842 | ||
| Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease | Q40298357 | ||
| Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. | Q40415499 | ||
| Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging | Q43062420 | ||
| High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters | Q43141731 | ||
| Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding | Q43290082 | ||
| Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET images | Q45347226 | ||
| Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease. | Q46009966 | ||
| Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics | Q46151649 | ||
| PET amyloid ligand [11C]PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment | Q46309418 | ||
| Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study | Q46373170 | ||
| The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics | Q46544681 | ||
| Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease | Q46956885 | ||
| Imaging beta-amyloid burden in aging and dementia. | Q48168226 | ||
| PET imaging of amyloid deposition in patients with mild cognitive impairment | Q48169392 | ||
| The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. | Q48256830 | ||
| Risk factors for dementia in the cardiovascular health cognition study | Q48395439 | ||
| Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease | Q48421563 | ||
| Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study | Q48530028 | ||
| Phases of A beta-deposition in the human brain and its relevance for the development of AD. | Q48567985 | ||
| Age, neuropathology, and dementia | Q48597534 | ||
| Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging | Q48748346 | ||
| Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease | Q48975406 | ||
| Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. | Q50758048 | ||
| [11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease | Q60451990 | ||
| The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado | Q72290644 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 751-761 | |
| P577 | publication date | 2013-04-17 | |
| P1433 | published in | Annals of Neurology | Q564414 |
| P1476 | title | In vivo assessment of amyloid-β deposition in nondemented very elderly subjects | |
| P478 | volume | 73 |
| Q35987278 | APOε2 and education in cognitively normal older subjects with high levels of AD pathology at autopsy: findings from the Nun Study |
| Q35957099 | Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease |
| Q31033082 | Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia |
| Q89626412 | Alcohol Consumption, Brain Amyloid-β Deposition, and Brain Structural Integrity Among Older Adults Free of Dementia |
| Q43161462 | Amyloid PET imaging: applications beyond Alzheimer's disease |
| Q33599047 | Amyloid burden and neural function in people at risk for Alzheimer's Disease |
| Q88475507 | Amyloid deposition and brain structure as long-term predictors of MCI, dementia, and mortality |
| Q30303122 | Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old |
| Q38270148 | Amyloid-beta and depression in healthy older adults: a systematic review. |
| Q58129974 | Apolipoproteins and Alzheimer's pathophysiology |
| Q30409084 | Arterial stiffness and β-amyloid progression in nondemented elderly adults. |
| Q92921065 | Association Between Amyloid-β, Small-vessel Disease, and Neurodegeneration Biomarker Positivity, and Progression to Mild Cognitive Impairment in Cognitively Normal Individuals |
| Q39189440 | Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype. |
| Q27345258 | Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results |
| Q38979999 | Biomarkers for the Early Detection and Progression of Alzheimer's Disease |
| Q48362816 | Case 1-2017. A 70-Year-Old Woman with Gradually Progressive Loss of Language |
| Q48445964 | Cerebral Amyloid Deposition and Dual-Tasking in Cognitively Normal, Mobility Unimpaired Older Adults |
| Q30413572 | Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches. |
| Q35529715 | Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum |
| Q30413904 | Cognitive trajectories associated with β-amyloid deposition in the oldest-old without dementia |
| Q39301541 | Detectable Neuropsychological Differences in Early Preclinical Alzheimer's Disease: A Meta-Analysis |
| Q33581237 | Diagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage |
| Q31162702 | Future Directions in Imaging Neurodegeneration |
| Q58560845 | Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging |
| Q35060487 | Hippocampal glutamate NMDA receptor loss tracks progression in Alzheimer's disease: quantitative autoradiography in postmortem human brain |
| Q35229601 | Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan |
| Q36827330 | Individual estimates of age at detectable amyloid onset for risk factor assessment |
| Q89891729 | Longitudinal Maintenance of Cognitive Health in Centenarians in the 100-plus Study |
| Q53397288 | Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ɛ4 genotype. |
| Q30406139 | Markers of cholesterol transport are associated with amyloid deposition in the brain. |
| Q38836004 | Molecular and cellular pathophysiology of preclinical Alzheimer's disease |
| Q92513074 | N-of-1 Clinical Trials in Nutritional Interventions Directed at Improving Cognitive Function |
| Q30680866 | Neuroimaging and genetic risk for Alzheimer's disease and addiction-related degenerative brain disorders |
| Q38991608 | Polyphenols Beyond Barriers: A Glimpse into the Brain. |
| Q37406073 | Psychological, behavioral and social effects of disclosing Alzheimer's disease biomarkers to research participants: a systematic review. |
| Q30409644 | Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults. |
| Q36146058 | Reduced binding of Pittsburgh Compound-B in areas of white matter hyperintensities |
| Q93055983 | Relationship of amyloid-β1-42 in blood and brain amyloid: Ginkgo Evaluation of Memory Study |
| Q35581060 | Review of 'the potential role of arterial stiffness in the pathogenesis of Alzheimer's disease'. |
| Q47926474 | Small-molecule PET Tracers for Imaging Proteinopathies |
| Q35940991 | Subjective Cognitive Complaints, Personality and Brain Amyloid-beta in Cognitively Normal Older Adults |
| Q46454611 | Synergistic effects of ischemia and β-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment |
| Q89051261 | The Relationship of Current Cognitive Activity to Brain Amyloid Burden and Glucose Metabolism |
| Q45987495 | The association of Aβ amyloid and composite cognitive measures in healthy older adults and MCI. |
| Q30670885 | The common dementias: a pictorial review. |
| Q92451639 | The effect of amyloid deposition on longitudinal resting-state functional connectivity in cognitively normal older adults |
| Q92239415 | The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies |
| Q34484708 | The overlap between vascular disease and Alzheimer's disease--lessons from pathology |
| Q38760636 | The pleiotropic vasoprotective functions of high density lipoproteins (HDL). |
| Q39128635 | The relationship between amyloid deposition, neurodegeneration, and cognitive decline in dementia. |
| Q26830467 | The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associations |
| Q30666527 | Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings |
| Q41071514 | Vascular Health Indices and Cognitive Domain Function: Singapore Longitudinal Ageing Studies |
Search more.